| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |